Skip to main content

Thermo Fisher Scientific Value Stock - Dividend - Research Selection

Thermo fisher scientific

ISIN: US8835561023 , WKN: 857209

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


The Zacks Analyst Blog Highlights JPMorgan Chase, Thermo Fisher, Arista Networks, United Homes Group and GSI

2024-09-10
JPMorgan Chase, Thermo Fisher, Arista Networks, United Homes Group and GSI are included in this Analyst Blog.

Top Research Reports for JPMorgan, Thermo Fisher & Arista Networks

2024-09-09
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Thermo Fisher Scientific Inc. (TMO) and Arista Networks, Inc. (ANET), as well as two micro-cap stocks United Homes Group, Inc. (UHG) and GSI Technology, Inc. (GSIT).

A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

2024-09-08
Key Insights Thermo Fisher Scientific's estimated fair value is US$720 based on 2 Stage Free Cash Flow to Equity...

Dividend Champion, Contender, And Challenger Highlights: Week Of September 8

2024-09-07
Stay up to date on dividend activity with our weekly summary for Dividend Champions, Contenders, and Challengers, plus info on ex-dividend and pay dates.

Election 2024: Where To Put Your Money Ahead of the Vote

2024-09-06
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Thermo Fisher Scientific (TMO) presents at Morgan Stanley 22nd Annual Global Healthcare Conference - Conference Call Transcript

2024-09-05
Thermo Fisher Scientific (NYSE:TMO) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 8:30 AM ETCompany ParticipantsMarc Casper -...

Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity

2024-09-05
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Russell companies with the lowest tax rates expected to generate $1B in 2025 – GS

2024-09-05
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Interesting TMO Put And Call Options For October 25th

2024-09-05
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Is Thermo Fisher Scientific Inc. (TMO) the Best Cancer Stock to Buy Now?

2024-09-04
We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against the other cancer stocks. Global Oncology Market Overview and Drug Shortages In 2022, the global oncology market was valued at approximately $203.42 billion […]